ALK and histiocytoma, Angiomatoid fibrous: The mechanism of this unusual ALK immunohistochemical positivity without any molecular basis still remains a mystery and warrants further investigation, as, in the future, ALK inhibitors such as crizotinib might be a potential player in the treatment of AFH.